{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Thiamine (Pabrinex)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To treat potential Wernicke's Encephalopathy, a reversible cause of ophthalmoplegia and ataxia Low risk intervention with high potential benefit\n\n*   **Treatment:** Dexamethasone\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Withhold until neuroimaging and potentially CSF/biopsy are completed Premature administration can cause lysis of Primary CNS Lymphoma cells, obscuring diagnosis\n\n*   **Treatment:** Venous Thromboembolism Prophylaxis\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Patient has reduced mobility and is being admitted, increasing thrombosis risk\n\n\ntreatments = [{\"treatment\": \"Intravenous Thiamine (Pabrinex)\", \"timing\": \"Start Now\", \"reasons\": [\"To treat potential Wernicke's Encephalopathy, a reversible cause of ophthalmoplegia and ataxia\", \"Low risk intervention with high potential benefit\"]}, {\"treatment\": \"Dexamethasone\", \"timing\": \"Delay\", \"reasons\": [\"Withhold until neuroimaging and potentially CSF/biopsy are completed\", \"Premature administration can cause lysis of Primary CNS Lymphoma cells, obscuring diagnosis\"]}, {\"treatment\": \"Venous Thromboembolism Prophylaxis\", \"timing\": \"Start Now\", \"reasons\": [\"Patient has reduced mobility and is being admitted, increasing thrombosis risk\"]}]"
}